Learn More
Apexbio Technology LLC Oxaliplatin, 61825-94-3, MFCD00866327, 50 mg

Supplier: Apexbio Technology LLC A864850
MF: C8H14N2O4Pt, MW: 397.29, Solubility: 37.25mg/mL in DMSO, 3.94mg/mL in H2O with gentle warming. Oxaliplatin inhibits DNA synthesis, primarily by conforming DNA adducts. Oxaliplatin, a platinum compound, has a broad spectrum of anti-tumor activity and has demonstrated a lack of cross-resistance with other platinum compounds. Oxaliplatin induces primary and secondary DNA lesions that lead to cell apoptosis.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.